Insider Trading History of Fernandes Prabhavathi

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Fernandes Prabhavathi since 2014. This trader's CIK number is 1540883. At the time of last reporting, Fernandes Prabhavathi was the Director of Ocugen, Inc.. (stock ticker symbol OCGN). Also see all insider trading activities at Ocugen, Inc..

Note that in the past Fernandes Prabhavathi also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Melinta Therapeutics, Inc. /new/ (CEMP) by Fernandes Prabhavathi

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 CEMP 0 $0 9,000 $321,488 37,389 $284,268
2014 CEMP 3,500 $30,100 0 $0 12,105 $17,310

Yearly summary of insider trading at Ocugen, Inc. (OCGN) by Fernandes Prabhavathi

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 OCGN 0 $0 33,500 $274,700 33,500 $35,342


Insider trading activities at 2 companies by Fernandes Prabhavathi:

1. Melinta Therapeutics, Inc. /new/ (CEMP)

2. Ocugen, Inc. (OCGN)

Table 1. Insider trading of Melinta Therapeutics, Inc. /new/ (CEMP) by Fernandes Prabhavathi

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-05-22 CEMP Sale 9,000 35.72 321,488
2015-05-22 CEMP Option Ex 37,389 7.60 284,268
2014-05-14 CEMP Option Ex 12,105 1.43 17,310
2013-05-09 CEMP Buy 3,500 8.60 30,100

Table 2. Insider trading of Ocugen, Inc. (OCGN) by Fernandes Prabhavathi

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-05-25 OCGN Sale 33,500 8.20 274,700
2021-05-25 OCGN Option Ex 33,500 1.05 35,342

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fernandes Prabhavathi (Director of Ocugen, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.